8 - 14 February 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Progression of cognitive symptoms varies
Stem cells effective in some people with SPMS
Stem cell treatment was effective in people with secondary progressive MS who still showed signs of inflammation on MRI scans, according to a small Italian study. Over ten years, twenty of the 26 participants saw their MS either stabilise or progress by one more EDSS point and then stabilise
Source: National MS Society (USA)
MS Trust link: Stem cell treatment
FSA sets CBD oil registration deadline
Due to concerns about the quality and ingredients of products currently on sale, the Food Standards Agency (FSA) has announced that in order to remain on the market, products containing CBD will need to be registered by the end of March 2021. There is also advice on the maximum daily dose and on using CBD oil when pregnant, breastfeeding or on other medication
MS Trust link: Cannabis
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
My MS and my mental health
16 Nov 2020 - 00:00
In his latest blog, Ian Daly speaks candidly about his own experience with depression and urges others to seek help if needed.